Impact BioMedical
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $7 | $18 | $7 | $0 |
Gross Profit | -1,267 | 17 | -4 | -283 |
EBITDA | 12,328 | -925 | -13,804 | -724 |
EBIT | 12,042 | -1,213 | -14,092 | -1,007 |
Net Income | 5,245 | -1,470 | -14,346 | -1,267 |
Net Change In Cash | 7 | 18 | 7 | 0 |
Free Cash Flow | 99 | -613 | -693 | |
Cash | 3 | 12 | 624 | 1,318 |
Basic Shares | 31,550 | 12,185 | 12,185 | 12,062 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $32 | $2,331 | $1,029 | $50 |
Gross Profit | -1,537 | 2,331 | 1,029 | 50 |
EBITDA | -3,125 | -1,539 | -2,843 | -6,301 |
EBIT | -4,270 | -1,882 | -3,963 | -7,414 |
Net Income | -11,838 | -2,051 | -4,336 | -7,051 |
Net Change In Cash | 32 | 2,331 | 1,029 | 50 |
Free Cash Flow | -1,890 | -5,635 | -2,869 | -4,428 |
Cash | 3 | 1,999 | 1 | 2 |
Basic Shares | 31,550 | 41,754 | 191,298 | 11,497 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | $0.05 |
2025-09-30 | -$0.12 |
2025-06-30 | -$1.18 |
2025-03-31 | -$0.11 |